Tenex Medical Investors

Tenex focuses on early-stage medical ventures, typically seed and Series A rounds. The firm enters when companies have initial prototypes and are building clinical evidence, before broad commercial rollout. This places it at the pre-revenue or early-revenue inflection point where regulatory clearance is the next major milestone.

The firm invests across medical devices, diagnostics, and digital health. Its medtech focus includes therapeutic and monitoring devices pursuing FDA 510(k) or CE mark pathways. Digital health investments center on platforms that improve clinical workflow or patient outcomes in regulated environments.

Tenex's Burlingame location provides proximity to the Bay Area's medtech innovation cluster, including Stanford's Biodesign program, UCSF clinical researchers, and the regional device-company spinout ecosystem. The team evaluates opportunities through clinical advisor networks and syndicate relationships with specialized healthcare funds.

Tenex participates in both lead and co-investor roles across its early-stage medical deals. The firm collaborates in syndicated rounds with other healthcare-focused venture investors who bring complementary clinical, regulatory, or strategic operating expertise to portfolio companies.

Tenex operates as a dedicated asset manager focused on medical venture capital rather than a single-family office. Its structure is that of a specialized private equity firm managing third-party capital, with no disclosed connection to a specific family wealth origin or multi-family office platform.